Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease

Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD

“…However, the effect of pharmacotherapy for psychological disorders on the risk of exacerbations and hospitalizations in patients with COPD has not been shown. 57 Pulmonary rehabilitation and psychotherapy have been shown to reduce anxiety and depressive symptoms and improve quality of life in patients with COPD, [58][59][60][61][62] but the overall use of pulmonary rehabilitation in the COPD population is low. 63 Many of these patients with low socioeconomic status and psychological disorders get admitted to safety net hospitals, so readmission rate could vary in proportion to the number of patients with these psychological disorders cared for by a safety net hospital.…”

Depression and anxiety in patients with COPD

“…However, its efficacy in COPD patients with comorbid anxiety or depression is unknown. A recent Cochrane [16] review highlighted pharmacological interventions for treatment of anxiety in COPD were inconclusive, because of the sub-optimal quality of trials and the non-significant results. Recently, a personalized, 9-session intervention (PID-C) was developed for patients with major depression and severe COPD [17].…”

Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review

“…Pharmacological interventions are commonly used to treat depression and anxiety in patients with COPD. Evidence for antidepressant therapy to overcome these mood disorders in COPD is limited 59–61 . There is a lack of randomized controlled trials to assess the effects of pharmacological interventions in this population.…”